• Align Research Top 10 Picks for 2019

    January 3, 2019 | Posted by

    To say that 2018 was a “trying” year is somewhat of an understatement. For many small and micro cap stocks, particularly the capital hungry ones and those where delivery by management of market expectations was non-existent or lacking, this resulted in almost decimatory declines for existing shareholders. The table below of the wipeouts suffered by […]

  • Statement to Widecells shareholders

    October 22, 2018 | Posted by

    We relay today to Widelcells Group Plc shareholders that following close liaison between Chairman Peter Presland and ourselves this last couple of weeks that the requisition we served in relation to Director changes at the company has now been withdrawn. We believe that almost all of our intended changes to the Board will occur as […]

  • Statement re Widecells Research

    September 27, 2018 | Posted by

    It is exceptionally rare for us to make a public statement in the manner we do here in relation to a recent corporate client that we had backed in the case of Widecells Research. However, such is the sheer incredulity at the 3 RNS’s put out today that we are galvanised into action. In essence, […]

  • Zak Mir interviews Joao Andrade, CEO of Widecells

    July 16, 2018 | Posted by

    Zak Mir interviews Joao Andrade, CEO of Widecells. Click the play button to listen to the audio. https://zakmir.files.wordpress.com/2018/07/joao-widecells_2018-07-16_11-10-58.mp3 Key points discussed: Why are stem cells significant and how is Widecells taking advantage? How competitive is the market for stem cell heath care insurance? In which countries do you see the best growth opportunities? Do you […]